Skip to main content
Equibles

Rachel Haurwitz, Ph.D.

Seer, Inc. (SEER)

Equibles does not estimate personal net worth.

Get an email with a short summary when Seer, Inc. publishes a filing, an earnings call transcript or a press release.

Get SEER alerts

About Rachel Haurwitz, Ph.D.

Seer, Inc. reported in an 8-K filed July 12, 2024 that Rachel Haurwitz, Ph.D. resigned as member of the Company's Board of Directors, effective July 8, 2024. Seer, Inc. reported in an 8-K filed December 22, 2023 that Rachel Haurwitz, Ph.D. was appointed Audit Committee member. Seer, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Seer, Inc. includes Omid Farokhzad (CEO and Board Member), Charles Endweiss (CFO and Chief Accounting Officer), Elona Kogan (General Counsel) and 7 others.

“On July 8, 2024, Rachel Haurwitz, Ph.D. informed Seer, Inc. (the "Company") of her resignation as a member of the Company's Board of Directors (the "Board") and all committees thereof, effective immediately (the "Director Resignation").”
Seer, Inc. Form 8-K, filed July 12, 2024 · Read the filing
“Also, following Ms. Friedman's resignation, the Board appointed Rachel Haurwitz, Ph.D. to the Audit Committee of the Board (the "Audit Committee") and appointed Meeta Gulyani as the Chair of the Audit Committee.”
Seer, Inc. Form 8-K, filed December 22, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Seer, Inc.

Recent activity